Citations 2
Association of immune-related thyroid disorders with pembrolizumab (pembro, MK-3475) in patients (pts) with advanced melanoma treated in KEYNOTE-001.
Kefford, Richard , Hodi, F. Stephen , Hamid, Omid , Gangadhar, Tara C., Dronca, Roxana , Patnaik, Amita , Zarour, Hassane M. , Hwu, Wen‐Jen , Giannotti, Maxine, Li, Xiaoyun , Ebbinghaus, Scot, Kang, Soonmo Peter, Robert, Caroline , Joshua, Anthony M. , Joseph, Richard W. , Wolchok, Jedd D. , Weber, Jeffrey S. , Hersey, Peter , Daud, Adil , Ribas, Antoni
Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 9050-9050
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
Ribas, Antoni , Hamid, Omid , Daud, Adil , Hodi, F. Stephen , Kefford, Richard , Joshua, Anthony M. , Patnaik, Amita , Hwu, Wen-Jen , Weber, Jeffrey S. , Gangadhar, Tara C., Hersey, Peter , Dronca, Roxana , Joseph, Richard W. , Zarour, Hassane M. , Lawrence, Donald P. , Algazi, Alain P. , Rizvi, Naiyer A. , Hoffner, Brianna, Mateus, Christine , Gergich, Kevin, Lindia, Jill A., Giannotti, Maxine, Li, Xiaoyun , Ebbinghaus, Scot, Kang, Soonmo Peter, Robert, Caroline , Wolchok, Jedd D. , Hwu, Wen‐Jen , Chmielowski, Bartosz , Daud, Adil I , Weber, Jeffrey
JAMA | April 19, 2016 | Volume: 315 | Issue: 15 | Pages: 1600